SCHEMBL17658451

SCHEMBL17658451

c1ccc(N(c2ccc3c(c2)oc2c4ccc(-c5ccc(N(c6ccccc6)c6cccc7c6oc6ccccc67)cc5)cc4c4ccccc4c32)c2ccc3oc4ccccc4c3c2)cc1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 2/20 0.32
PLA2G4A P47712 2/20 0.32
ALOX5 P09917 1/20 0.32
MMP12 P39900 1/20 0.31
MMP13 P45452 1/20 0.31
PLA2G10 O15496 1/20 0.31
PTPRF P10586 1/20 0.31
PTPN2 P17706 1/20 0.31
PTPN1 P18031 1/20 0.31
AHR P35869 2/20 0.30
KDM4E B2RXH2 2/20 0.30
MEN1 O00255 2/20 0.30
MAPT P10636 2/20 0.30
HPGD P15428 2/20 0.30
KMT2A Q03164 2/20 0.30
NPC1 O15118 1/20 0.30
ALDH1A1 P00352 1/20 0.30
RAB9A P51151 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
CYP3A4 P08684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17658417 0.96 ALOX5 (0.34) PLA2G2APLA2G4AALOX5MMP12MMP13
SCHEMBL17658439 0.96 ALOX5 (0.34) PLA2G2APLA2G4AALOX5MMP12MMP13
SCHEMBL17658420 0.95 PLA2G2A (0.35) PLA2G2APLA2G4AALOX5MMP12MMP13
SCHEMBL17658443 0.95 ALOX5 (0.35) PLA2G2APLA2G4AALOX5MMP12MMP13
SCHEMBL17658391 0.95 MAPT (0.33) ALOX5AHRKDM4EMEN1MAPT
SCHEMBL17658475 0.94 ALOX5 (0.34) PLA2G2APLA2G4AALOX5MMP12MMP13
SCHEMBL17658473 0.94 ALOX5 (0.34) PLA2G2APLA2G4AALOX5MMP12MMP13
SCHEMBL17658456 0.94 ALOX5 (0.34) PLA2G2APLA2G4AALOX5MMP12MMP13
SCHEMBL17658382 0.94 ALOX5 (0.34) PLA2G2APLA2G4AALOX5AHRKDM4E
SCHEMBL17658465 0.93 ALOX5 (0.35) PLA2G2APLA2G4AALOX5MMP12MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9923147-B2 Organic light emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-20 US disclosed
US-9923147-B2 Organic light emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-20 US disclosed
US-9856243-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-02 US disclosed
US-20160329501-A1 ORGANIC LIGHT EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2016-11-10 US disclosed
US-20160329501-A1 ORGANIC LIGHT EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2016-11-10 US disclosed
US-20160099423-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-04-07 US disclosed
US-20160099423-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160099423-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, MCM4 PLA2G2A 4629/4885PLA2G4A 4587/4885ALOX5 2708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.